Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
The Soborro Portfolio Risk Profiler serves as an online tool designed for evaluating the potential behavior of investment portfolios in various economic and market climates. By allowing users to establish a portfolio and select long-term economic scenarios, the platform enables them to analyze projected outcomes across different scenario paths. The results reveal possible gains and losses, assisting users in understanding how their portfolio's exposure to equities, interest rates, inflation, credit, and other modeled factors influence overall risk. This analysis is particularly beneficial for asset managers, investment researchers, and professionals who advise pension funds and insurance companies, as they can utilize it to compare different allocations, validate investment assumptions, facilitate portfolio construction, and evaluate risk over extended time frames. Furthermore, the scenario outcomes aid in both investment research and client assessments, providing valuable insights. Offered as a cloud-based service, the Portfolio Risk Profiler is accessible through a subscription model that enhances its usability for a wide range of financial professionals.
Description
The Vantage™ Risk and Budgeting Manager from Fiserv provides a comprehensive overview of essential data necessary for effective business management. By connecting various interrelated business functions, it enables informed decision-making through insightful analytics. You can efficiently manage balance sheet risk utilizing a selection of gap and duration analysis, income simulation, and economic value analysis techniques tailored for asset/liability management. This tool allows for the examination of specific balance sheet elements or a holistic view of the entire balance sheet. Furthermore, you can enhance your simulations to encompass non-interest income and expenses alongside net interest margin. Set various forecasting parameters, such as interest rates, pricing strategies, prepayments, and growth projections. You have the flexibility to combine different assumptions and conduct stress tests on the balance sheet in response to interest rate fluctuations, thereby assessing the comparative risks and benefits of various business strategies. This functionality not only promotes better financial oversight but also aids in strategic planning for future growth.
API Access
Has API
No
API Access
Has API
No
Screenshots View All
No images available
Integrations
ARGO
No
Pricing Details
$199/month
Standard subscription: $199 per month.
Free Trial
No
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
No
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
No
Types of Training
Training Docs
No
Webinars
No
Live Training (Online)
No
In Person
No
Types of Training
Training Docs
No
Webinars
No
Live Training (Online)
No
In Person
No
Vendor Details
Company Name
Soborro Research
Founded
2020
Country
United Kingdom
Website
www.soborro.com/products/risk-profiler
Vendor Details
Company Name
Fiserv
Founded
1984
Country
United States
Website
fiserv.com
Product Features
Financial Risk Management
Compliance Management
No
Credit Risk Management
No
For Hedge Funds
No
Liquidity Analysis
No
Loan Portfolio Management
No
Market Risk Management
No
Operational Risk Management
No
Portfolio Management
No
Portfolio Modeling
No
Risk Analytics Benchmarks
No
Stress Tests
No
Value At Risk Calculation
No
Product Features
Financial Reporting
"What If" Scenarios
Yes
Audit Trail
Yes
Balance Sheet
Yes
Cash Management
Yes
Consolidation / Roll-Up
Yes
Forecasting
Yes
General Ledger
Yes
Income Statements
Yes
Multi-Company
Yes
Multi-Department / Project
Yes
Profit / Loss Statement
Yes